Literature DB >> 15022353

Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis.

Adla B Hassan, Liene Nikitina-Zake, Carani B Sanjeevi, Ingrid E Lundberg, Leonid Padyukov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15022353     DOI： 10.1002/art.20208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  14 in total

Review 1.  Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review.

Authors:  Dan Chen; Xiao-bing Wang; Yan Zhou; Xiao-chun Zhu
Journal:  Rheumatol Int       Date:  2013-05-29       Impact factor: 2.631

2.  A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.

Authors:  Adam Schiffenbauer; Megha Garg; Christine Castro; Angelina Pokrovnichka; Galen Joe; Joseph Shrader; Imelda Victoria Cabalar; Sara Faghihi-Kashani; Michael O Harris-Love; Paul H Plotz; Frederick W Miller; Mark Gourley
Journal:  Semin Arthritis Rheum       Date:  2017-10-16       Impact factor: 5.532

3.  Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Lisa G Rider; Adam Schiffenbauer; Ira N Targoff; Karen Malley; Janardan P Pandey; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2008-10

4.  Genetic risk and protective factors for the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Frederick W Miller
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 5.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.

Authors:  Gulnara Mamyrova; Terrance P O'Hanlon; Laura Sillers; Karen Malley; Laura James-Newton; Christina G Parks; Glinda S Cooper; Janardan P Pandey; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2008-12

7.  Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han.

Authors:  Qian Wang; Si Chen; Yuan Li; Ping Li; Chanyuan Wu; Ziyan Wu; Qingjun Wu; Fei Sun; Jing Li; Wenjie Zheng; Chuiwen Deng; Fengchun Zhang; Yongzhe Li
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 8.  Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2011-01-21       Impact factor: 6.682

Review 9.  Recent advances in the immunogenetics of idiopathic inflammatory myopathy.

Authors:  Hector Chinoy; Janine A Lamb; William E R Ollier; Robert G Cooper
Journal:  Arthritis Res Ther       Date:  2011-05-26       Impact factor: 5.156

10.  Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

Authors:  F W Miller; W Chen; T P O'Hanlon; R G Cooper; J Vencovsky; L G Rider; K Danko; L R Wedderburn; I E Lundberg; L M Pachman; A M Reed; S R Ytterberg; L Padyukov; A Selva-O'Callaghan; T R Radstake; D A Isenberg; H Chinoy; W E R Ollier; P Scheet; B Peng; A Lee; J Byun; J A Lamb; P K Gregersen; C I Amos
Journal:  Genes Immun       Date:  2015-08-20       Impact factor: 2.676
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.